Clinical Trials Browser

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT05183984 2024-10-16

NIRVANA-1

Phase 2 Recruiting

390 enrolled

Gynecologic

Ovarian Neoplasms

NCT03949283 2024-08-22

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Phase 3 Active not recruiting

150 enrolled

Gynecologic

Ovarian Neoplasms

NCT05684731 2024-08-13

K19017-004

Phase 1 Recruiting

30 enrolled

Gynecologic

Ovarian Neoplasms

NCT03539406 2024-08-09

INTRO

Phase 1 Completed

11 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06376604 2024-04-19

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

Phase NA Recruiting

30 enrolled

Gynecologic

Intermittent Fasting, Ovarian Neoplasms

NCT03329950 2024-03-28

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Phase 1 Completed

132 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Cholangiocarcinoma, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Hyper-IgM Immunodeficiency Syndrome

NCT05143970 2024-03-20

CHANCES

Phase 1 Unknown

27 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT03757858 2024-02-07

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Phase 1/2 Completed

40 enrolled

Gynecologic

Neoplasm Metastasis, Neoplasms, Pelvic Neoplasms

NCT05076942 2023-08-01

GROINSS-VIII

Phase 2 Recruiting

157 enrolled

Gynecologic

Lymphatic Metastasis, Vulvar Neoplasms

NCT04201561 2023-06-26

SELENIUM

Phase 3 Unknown

68 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT02855944 2023-06-09

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Phase 3 Completed

349 enrolled 29 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT03642132 2023-04-06

JAVELIN OVARIAN PARP100

Phase 3 Terminated

79 enrolled 18 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05541146 2023-03-23

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

Phase 2 Unknown

30 enrolled

GastrointestinalGynecologic

Carcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT02759588 2023-01-05

GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Phase 1/2 Completed

46 enrolled

Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms, Poxviridae Infections, Vaccinia, Virus Diseases

NCT05524389 2022-11-23

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Phase 3 Not yet recruiting

624 enrolled

Gynecologic

Endometrial Neoplasms

NCT05607329 2022-11-07

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

Phase NA Recruiting

400 enrolled

Gynecologic

Ovarian Neoplasms

NCT05437692 2022-10-12

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Phase 2 Unknown

19 enrolled

Gynecologic

Locally Advanced Cervical Cancer

NCT01809379 2022-07-08

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Phase 2 Completed

69 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT05422183 2022-06-16

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Phase 2 Unknown

20 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT04756713 2022-05-27

ReCure

Phase 3 Unknown

150 enrolled

Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT04795596 2022-04-15

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

Phase 2/3 Withdrawn

Gynecologic

Ovarian Neoplasms

NCT04188847 2022-03-15

First-line Chemotherapy for Recurrent Cervical Cancer

Phase 2 Completed

37 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03955367 2022-02-23

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

Phase 3 Unknown

638 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05170594 2021-12-28

A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

Phase 2 Unknown

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT04620954 2021-12-01

ORION-02

Phase 1/2 Unknown

31 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT05059782 2021-09-28

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Phase NA Unknown

150 enrolled

Gynecologic

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Clinical Trials

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Serplulimab for Locally Advanced Cervical Cancer

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Surgery for Relapsed Ovarian Cancer in Precision

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer

Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

PARCERII

Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer

SOCCER-P

BAROCCO

RAINBO

A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

NIRVANA-1

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

K19017-004

INTRO

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

CHANCES

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

GROINSS-VIII

SELENIUM

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

JAVELIN OVARIAN PARP100

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

ReCure

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

First-line Chemotherapy for Recurrent Cervical Cancer

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

ORION-02

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer